Fortress Biotech (FBIO) Operating Income (2016 - 2025)
Historic Operating Income for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to -$6.8 million.
- Fortress Biotech's Operating Income rose 6917.4% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$89.4 million, marking a year-over-year increase of 1567.65%. This contributed to the annual value of -$110.4 million for FY2024, which is 2245.51% up from last year.
- According to the latest figures from Q3 2025, Fortress Biotech's Operating Income is -$6.8 million, which was up 6917.4% from -$36.5 million recorded in Q2 2025.
- In the past 5 years, Fortress Biotech's Operating Income ranged from a high of -$6.8 million in Q3 2025 and a low of -$62.0 million during Q4 2021
- Moreover, its 5-year median value for Operating Income was -$36.6 million (2024), whereas its average is -$37.2 million.
- In the last 5 years, Fortress Biotech's Operating Income tumbled by 15511.67% in 2021 and then surged by 7288.21% in 2023.
- Quarter analysis of 5 years shows Fortress Biotech's Operating Income stood at -$62.0 million in 2021, then increased by 11.88% to -$54.6 million in 2022, then soared by 64.1% to -$19.6 million in 2023, then dropped by 21.52% to -$23.8 million in 2024, then surged by 71.42% to -$6.8 million in 2025.
- Its Operating Income was -$6.8 million in Q3 2025, compared to -$36.5 million in Q2 2025 and -$22.3 million in Q1 2025.